10% Carbohydrate Drink for Preventing Post-operative Nausea and Vomiting (PONV) After Spinal Morphine

Sponsor
Mahidol University (Other)
Overall Status
Completed
CT.gov ID
NCT01301404
Collaborator
(none)
120
1
2
16
7.5

Study Details

Study Description

Brief Summary

PONV after intrathecal morphine, occurs up to 30-40 percent. The patients having TKR normally are female, obese and non-smoker which are risk factors for PONV. Recently, a multimodal approach, combining several means to minimize PONV, has found wide acceptance as a standard of care. In our hospital, most of the patients are supposed to fast after midnight The oral rehydration therapy reduce patients thirst and increase his satisfaction, but whether or not this method can reduce the incidence of PONV after low dose (0.2 mg) intrathecal morphine is not investigated yet. The aim of this study is to investigate the effect of preoperative oral rehydration therapy on the incidence of PONV.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: 10% carbohydrate drink
Phase 1

Detailed Description

We enroll patients who are undergoing TKR under spinal anesthesia with 0.5% heavy bupivacaine 10-15 mg (2.0-3.0 ml)+ intrathecal morphine 0.2 mg+ femoral nerve block with 0.25% bupivacaine 20 ml.

The enrolled patients will fast after midnight and in the morning they are allowed to drink 10% carbohydrate drink or not to drink (according to their randomization). 400 ml of 10% carbohydrate drink is drunk between evening and midnight and extra water if needed in the study group. In the control group, the patients are allowed to drink until midnight. Total of water consumption between 18.00-24.00 will be recorded in both groups. In the morning, the study group will drink another 400 ml of 10% carbohydrate drink between 6 - 7 am. The premedications should not include sedation or GI mobility drugs. Before starting anesthesia, the patients will be asked some questions about thirsty, hungry, anxiety and nausea and weigh their feeling from 0-10.

The surgery and pain therapy will be tha same in both groups and the PONV (incidence, severity and rescue therapy) at recovery room and 24 hours postoperative period will be recorded.

Study Design

Study Type:
Interventional
Actual Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Oral Rehydration Therapy With 10% Carbohydrate Drink for Preventing Postoperative Nausea and Vomiting (PONV) After Low Dose of Spinal Morphine in Patients Undergoing Total Knee Replacement
Study Start Date :
Feb 1, 2011
Actual Primary Completion Date :
Jun 1, 2012
Actual Study Completion Date :
Jun 1, 2012

Arms and Interventions

Arm Intervention/Treatment
No Intervention: control

patient receive nothing

Experimental: carbohydrate drink

10%carbohydrate drink

Dietary Supplement: 10% carbohydrate drink
In the study group, 10% carbohydrate drink 400 ml will be given between 18-24 hr the night before surgery and another 400 ml will be drunk at 6-7 hr in the morning of surgery.
Other Names:
  • Green mate (orange favor)
  • Outcome Measures

    Primary Outcome Measures

    1. The incidence of postoperative nausea and vomiting after TKR [24 hours]

      Compare the incidence, severity and rescue therapy of PONV in control (fast)group a group and the study (carbohydrate drink) group

    Secondary Outcome Measures

    1. Incidence of hyperglycemia during perioperative period [24 hours]

      Regarding to the perioperative stress and carbohydrate drinking, we also measure blood sugar before and postoperation and compare their values between groups

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    50 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients are under going unilateral TKR, with ASA I-III who scheduled started in the morning list (before noon)
    Exclusion Criteria:
    • Diabetes

    • History of motion sickness

    • Chronic kidney disease (CKD, creatinine > 2 mg/dl)

    • Hiatus hernia or gastro esophageal reflux

    • Patients receiving drugs that might affect GI motility such as opioids

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Siriraj Hospital Bangkok Thailand 10700

    Sponsors and Collaborators

    • Mahidol University

    Investigators

    • Principal Investigator: Manee Raksakietisak, MD, Mahidol University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Manee Raksakietisak, Associate professor, Mahidol University
    ClinicalTrials.gov Identifier:
    NCT01301404
    Other Study ID Numbers:
    • 763/2553(EC2)
    First Posted:
    Feb 23, 2011
    Last Update Posted:
    Jul 19, 2013
    Last Verified:
    Jun 1, 2012
    Keywords provided by Manee Raksakietisak, Associate professor, Mahidol University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 19, 2013